-
Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution
Thursday, December 19, 2019Glenmark Pharmaceutical Inc., USA (“Glenmark”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level. The recalled lots of Ranitidine Tablets 150 mg and 300 mg, which are listed in Attachment B, are being recalled... Read More -
Medtronic Recalls SynchroMed II Implantable Drug Infusion Pump
Tuesday, December 17, 2019Medtronic received reports of early permanent motor stall due to the potential presence of foreign particles inside the pump motor assembly. Permanent motor stall could prevent the infusion of drugs to the patient, which could cause serious injury, such as drug withdrawal, the return of symptoms of... Read More -
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Twenty-Two Lots of Blood Administration Sets
Monday, December 2, 2019B. Braun Medical Inc. [B. Braun] initiated a voluntary recall of twenty-two (22) lots of Blood Administration Sets. The recalled blood administration sets are used to administer blood from a container to a patient's vascular system through an IV catheter inserted into a vein or central venous... Read More
Home
- About
- Careers
- Contact Us
- Medicare Quality Improvement (QIO)
- HSAG HQIC Partnership
-
ESRD Networks Home
- About Us
- Contact Us
- For Patients and Families
- For Providers
- ESRD Network 7
- ESRD Network 13
- ESRD Network 15
- ESRD Network 17
- ESRD Network 18
- HSAG ESRD Alerts, Recalls, and Notices
- Behavioral Health
- Continuing Education
- Data Management
- Emergency Preparedness
- Home Dialysis
- Infection Prevention
- Patient and Family Engagement (PFE)
- Readmissions and Hospitalizations
- Telemedicine
- Transplant
- Vaccinations
- Healthcare Policy and Quality Measurement
- Medicaid External Quality Review
- QPP Service Center
- Surveys
- Audit and Validation Services (HEDIS®/AMP)
- News